Literature DB >> 170069

The effect of fasting on tissue cyclic cAMP and plasma glucagon in the obese hyperglycemic mouse.

R L Lavine, N Voyles, P V Perrino, L Recant.   

Abstract

The effect of 48 h of fasting in C57B1/6J-ob/ob and +/+ mice on body weight (BW), blood glucose (BG), serum immunreactive insulin (IRI), plasma immunoreactive glucagon (IRG) and on tissue levels of cyclic adenosine monophosphate (cAMP) were studied. Both groups of mice lost weight and demonstrated a decrease in BG and IRI with fasting. However, the BG and IRI of the ob/ob animals were initially highter and remained higher than those of the 2% of their initial weight while the +/+ lost 14 %. The +/+ mice exhibited an increase in cAMP levels in skeletal muscle, fat and liver with fasting, while the ob/ob mice had increased levels of cAMP in fat, but not in muscle. They also had a paradoxical decrease in liver cAMP levels with fasting, and associated with this was the lack of stimulation of glycogenolysis. Glycogenolysis was significant in the livers of fasted +/+ mice. The plasma IRG levels of the fed ob/ob mice were significantly higher (1.8) times) than those of the fed +/+ mice. Islet cAMP levels were decreased with fasting in ob/ob mice. However, the levels were significantly higher in 48-h faster ob/ob mice compared to the fasted +/+ group. The apparent paradoxical response to fasting observed in the livers of the ob/ob mice remains unexplained.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170069     DOI: 10.1210/endo-97-3-615

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

1.  Lipolysis and cyclic AMP levels in epididymal adipose tissue of obese-hyperglycaemic mice.

Authors:  J P Dehaye; J Winand; J Christophe
Journal:  Diabetologia       Date:  1977-12       Impact factor: 10.122

2.  Physiological Regulation of Drug Metabolism and Transport: Pregnancy, Microbiome, Inflammation, Infection, and Fasting.

Authors:  Edward T Morgan; Joseph L Dempsey; Sylvie M Mimche; Tracey J Lamb; Supriya Kulkarni; Julia Yue Cui; Hyunyoung Jeong; Angela L Slitt
Journal:  Drug Metab Dispos       Date:  2018-03-07       Impact factor: 3.922

3.  Glucagon immunoreactivity in plasma from normal and dystrophic mice.

Authors:  B Ahrén; I Lundquist
Journal:  Diabetologia       Date:  1982-04       Impact factor: 10.122

4.  Altered liver glycogen metabolism in fed genetically obese mice.

Authors:  G van de Werve; F Assimacopoulos-Jeannet; B Jeanrenaud
Journal:  Biochem J       Date:  1983-11-15       Impact factor: 3.857

5.  Insulin secretion by the transplanted neonatal pancreas during food intake in fasted and fed rats.

Authors:  J H Strubbe; P van Wachem
Journal:  Diabetologia       Date:  1981-03       Impact factor: 10.122

6.  Obesity dysregulates fasting-induced changes in glucagon secretion.

Authors:  Jennifer H Stern; Gordon I Smith; Shiuwei Chen; Roger H Unger; Samuel Klein; Philipp E Scherer
Journal:  J Endocrinol       Date:  2019-11       Impact factor: 4.286

7.  Role of Insulin in the Regulation of Proprotein Convertase Subtilisin/Kexin Type 9.

Authors:  Ji Miao; Praveen V Manthena; Mary E Haas; Alisha V Ling; Dong-Ju Shin; Mark J Graham; Rosanne M Crooke; Jingwen Liu; Sudha B Biddinger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-05-28       Impact factor: 8.311

8.  Transcriptional activation of lipogenesis by insulin requires phosphorylation of MED17 by CK2.

Authors:  Jose A Viscarra; Yuhui Wang; Il-Hwa Hong; Hei Sook Sul
Journal:  Sci Signal       Date:  2017-02-21       Impact factor: 8.192

9.  Increased dose-response relationship of liver plasma membrane adenylate cyclase to glucagon stimulation in diabetic rats. A possible role of the guanyl nucleotide-binding regulatory protein.

Authors:  H Allgayer; W Bachmann; K D Hepp
Journal:  Diabetologia       Date:  1982-06       Impact factor: 10.122

10.  Fructose 2,6-bisphosphate in livers of genetically obese rats.

Authors:  L Hue; G van de Werve; B Jeanrenaud
Journal:  Biochem J       Date:  1983-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.